Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel compounds target the FtsZ protein in M. tuberculosis

Aug. 21, 2014

GlaxoSmithKline describes progress on HCV NS5A Inhibitors

Aug. 20, 2014

Hyaluronidse-2 as potential new marker for platelet activation and IBD

Aug. 20, 2014

Novel missense mutation in AR gene responsible for CAIS symptoms

Aug. 20, 2014

Novel HPLC system measures serum apoE-HDLc

Aug. 19, 2014

New potent and selective Wnt signaling inhibitor with in vivo activity

Aug. 19, 2014

TAXIS Pharmaceuticals presents novel antibacterial agents targeting FtsZ

Aug. 19, 2014

Novel nontreponemal EIA assay for the diagnosis of syphilis

Aug. 18, 2014

Novel glucocorticoid receptor agonists show selectivity for transrepression over transactivation

Aug. 18, 2014

Janssen describes different series of FLAP inhibitors for inflammatory diseases

Aug. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026